Annual EBIT
-$32.89 M
-$12.48 M-61.12%
December 31, 2023
Summary
- As of February 27, 2025, EFTR annual earnings before interest & taxes is -$32.89 million, with the most recent change of -$12.48 million (-61.12%) on December 31, 2023.
- During the last 3 years, EFTR annual EBIT has fallen by -$48.79 million (-306.93%).
- EFTR annual EBIT is now -287.29% below its all-time high of $17.56 million, reached on December 31, 2021.
Performance
EFTR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.09 M
+$287.00 K+3.43%
March 31, 2024
Summary
- As of February 27, 2025, EFTR quarterly earnings before interest & taxes is -$8.09 million, with the most recent change of +$287.00 thousand (+3.43%) on March 31, 2024.
- Over the past year, EFTR quarterly EBIT has increased by +$1.24 million (+13.30%).
- EFTR quarterly EBIT is now -141.38% below its all-time high of $19.54 million, reached on December 31, 2021.
Performance
EFTR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$31.65 M
+$1.24 M+3.77%
March 31, 2024
Summary
- As of February 27, 2025, EFTR TTM earnings before interest & taxes is -$31.65 million, with the most recent change of +$1.24 million (+3.77%) on March 31, 2024.
- Over the past year, EFTR TTM EBIT has increased by +$1.64 million (+4.91%).
- EFTR TTM EBIT is now -215.58% below its all-time high of $27.39 million, reached on March 31, 2022.
Performance
EFTR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EFTR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.1% | +13.3% | +4.9% |
| 3 y3 years | -306.9% | +13.3% | +4.9% |
| 5 y5 years | -306.9% | +13.3% | +4.9% |
EFTR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -287.3% | at low | -141.4% | +13.3% | -215.6% | +8.3% |
| 5 y | 5-year | -287.3% | at low | -141.4% | +13.3% | -215.6% | +8.3% |
| alltime | all time | -287.3% | at low | -141.4% | +13.3% | -215.6% | +8.3% |
EFFECTOR Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$8.09 M(-3.4%) | -$31.65 M(-3.8%) |
| Dec 2023 | -$32.89 M(+61.1%) | -$8.37 M(+10.8%) | -$32.89 M(-0.6%) |
| Sep 2023 | - | -$7.55 M(-1.2%) | -$33.08 M(-4.2%) |
| Jun 2023 | - | -$7.64 M(-18.0%) | -$34.52 M(+3.7%) |
| Mar 2023 | - | -$9.32 M(+8.9%) | -$33.29 M(+63.1%) |
| Dec 2022 | -$20.41 M | -$8.56 M(-4.7%) | -$20.41 M(-365.6%) |
| Sep 2022 | - | -$8.99 M(+40.2%) | $7.69 M(-70.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.41 M(-280.7%) | $26.04 M(-4.9%) |
| Mar 2022 | - | $3.55 M(-81.8%) | $27.39 M(+55.9%) |
| Dec 2021 | $17.56 M(+10.5%) | $19.54 M(+108.6%) | $17.56 M(-333.6%) |
| Sep 2021 | - | $9.37 M(-284.8%) | -$7.52 M(-68.9%) |
| Jun 2021 | - | -$5.07 M(-19.2%) | -$24.15 M(+26.6%) |
| Mar 2021 | - | -$6.28 M(+13.3%) | -$19.08 M(+49.0%) |
| Dec 2020 | $15.89 M | -$5.54 M(-23.7%) | -$12.80 M(+76.3%) |
| Sep 2020 | - | -$7.26 M | -$7.26 M |
FAQ
- What is eFFECTOR Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual EBIT year-on-year change?
- What is eFFECTOR Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly EBIT year-on-year change?
- What is eFFECTOR Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM EBIT year-on-year change?
What is eFFECTOR Therapeutics annual earnings before interest & taxes?
The current annual EBIT of EFTR is -$32.89 M
What is the all time high annual EBIT for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual earnings before interest & taxes is $17.56 M
What is eFFECTOR Therapeutics annual EBIT year-on-year change?
Over the past year, EFTR annual earnings before interest & taxes has changed by -$12.48 M (-61.12%)
What is eFFECTOR Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of EFTR is -$8.09 M
What is the all time high quarterly EBIT for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly earnings before interest & taxes is $19.54 M
What is eFFECTOR Therapeutics quarterly EBIT year-on-year change?
Over the past year, EFTR quarterly earnings before interest & taxes has changed by +$1.24 M (+13.30%)
What is eFFECTOR Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of EFTR is -$31.65 M
What is the all time high TTM EBIT for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM earnings before interest & taxes is $27.39 M
What is eFFECTOR Therapeutics TTM EBIT year-on-year change?
Over the past year, EFTR TTM earnings before interest & taxes has changed by +$1.64 M (+4.91%)